Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

Redhill Biopharma Announces Extinguishment Of Its Debt Obligations Under Credit Agreement Between Its U.S. Subsidiary And HCR Dated February 23, 2020, In Exchange For The Transfer Of Its Rights In Movantik To HealthCare Royalty’s (HCR) Affiliate

HCR will assume substantially all post-closing liabilities, and RedHill will retain substantially all pre-closing liabilities relating to Movantik (Naloxegol). HCR will retain security interests in certain RedHill assets

RDHL